company

BIOSENTRUM AS

4021 STAVANGER

Return on Equity
6,34 %
Current Ratio
1,2
Debt-to-Equity Ratio
−1,3
Key figures (NOK)2022
Revenue2 789 000
Net Income−141 000
Total Assets4 085 000
Total Equity−2 223 000
Income (NOK)2022
Revenue2 789 000
Expenditure2 847 000
Operating Profit−58 000
Financial Income7 000
Financial Costs90 000
Financial Balance−83 000
Earnings Before Tax−141 000
Tax0
Net Income−141 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets4 085 000
Total Assets4 085 000
Total Retained Equity−3 223 000
Total Equity−2 223 000
Total Long-Term Debt2 900 000
Total Current Debt3 408 000
Total Equity and Debt4 085 000
Cash flow (NOK)2022
Sales Income2 789 000
Other Income0
Revenue2 789 000
Cost of Goods Sold2 016 000
Salary Costs277 000
Depreciation0
Impairment0
Expenditure2 847 000
Operating Profit−58 000
Financial Income7 000
Financial Costs90 000
Financial Balance−83 000
Dividends0
Net Income−141 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments0
Cash, Bank146 000
Total Current Assets4 085 000
Total Assets4 085 000
Total Equity−2 223 000
Short-Term Group Debt0
Total Long-Term Debt2 900 000
Creditors2 832 000
Unpaid Taxes143 000
Dividends0
Other Current Debt433 000
Total Current Debt3 408 000
Total Equity and Debt4 085 000
Financial indicators2022
Return on Equity6,34 %
Debt-to-Equity Ratio−1,3
Operating Profit Margin−2,08 %
Current Ratio1,2
Quick Ratio1,2
Equity Ratio−0,54
Gross Profit Margin27,72 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English